nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—F2—liver cancer	0.75	1	CbGaD
Argatroban—F2—posterior vena cava—liver cancer	0.0384	0.351	CbGeAlD
Argatroban—F2—hepatic artery—liver cancer	0.0339	0.31	CbGeAlD
Argatroban—F2—portal vein—liver cancer	0.0295	0.269	CbGeAlD
Argatroban—CYP3A5—Sorafenib—liver cancer	0.0272	0.615	CbGbCtD
Argatroban—CYP3A4—Sorafenib—liver cancer	0.0106	0.24	CbGbCtD
Argatroban—CYP3A4—Doxorubicin—liver cancer	0.00644	0.145	CbGbCtD
Argatroban—F2—gall bladder—liver cancer	0.00506	0.0462	CbGeAlD
Argatroban—Haematoma—Sorafenib—liver cancer	0.00197	0.041	CcSEcCtD
Argatroban—Pleural effusion—Sorafenib—liver cancer	0.00162	0.0337	CcSEcCtD
Argatroban—Myocardial ischaemia—Sorafenib—liver cancer	0.00154	0.0321	CcSEcCtD
Argatroban—F2—liver—liver cancer	0.00148	0.0136	CbGeAlD
Argatroban—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.00137	0.0286	CcSEcCtD
Argatroban—Bullous eruption—Epirubicin—liver cancer	0.00116	0.0241	CcSEcCtD
Argatroban—Bullous eruption—Doxorubicin—liver cancer	0.00107	0.0223	CcSEcCtD
Argatroban—Renal failure acute—Sorafenib—liver cancer	0.000975	0.0203	CcSEcCtD
Argatroban—Kidney function abnormal—Epirubicin—liver cancer	0.000949	0.0197	CcSEcCtD
Argatroban—Cardiac failure—Sorafenib—liver cancer	0.000923	0.0192	CcSEcCtD
Argatroban—Kidney function abnormal—Doxorubicin—liver cancer	0.000878	0.0183	CcSEcCtD
Argatroban—Pneumonia—Sorafenib—liver cancer	0.000698	0.0145	CcSEcCtD
Argatroban—Acute coronary syndrome—Sorafenib—liver cancer	0.000684	0.0142	CcSEcCtD
Argatroban—Myocardial infarction—Sorafenib—liver cancer	0.00068	0.0141	CcSEcCtD
Argatroban—Haematemesis—Epirubicin—liver cancer	0.00066	0.0137	CcSEcCtD
Argatroban—Thrombosis—Epirubicin—liver cancer	0.000648	0.0135	CcSEcCtD
Argatroban—Haemoglobin—Sorafenib—liver cancer	0.000626	0.013	CcSEcCtD
Argatroban—Haemorrhage—Sorafenib—liver cancer	0.000623	0.013	CcSEcCtD
Argatroban—Haemoptysis—Epirubicin—liver cancer	0.000619	0.0129	CcSEcCtD
Argatroban—Haematemesis—Doxorubicin—liver cancer	0.000611	0.0127	CcSEcCtD
Argatroban—CYP3A5—liver—liver cancer	0.000601	0.00549	CbGeAlD
Argatroban—Thrombosis—Doxorubicin—liver cancer	0.000599	0.0125	CcSEcCtD
Argatroban—Pleural effusion—Epirubicin—liver cancer	0.000599	0.0124	CcSEcCtD
Argatroban—Haemoptysis—Doxorubicin—liver cancer	0.000573	0.0119	CcSEcCtD
Argatroban—Angiopathy—Sorafenib—liver cancer	0.000565	0.0118	CcSEcCtD
Argatroban—Pleural effusion—Doxorubicin—liver cancer	0.000554	0.0115	CcSEcCtD
Argatroban—Vasodilation—Epirubicin—liver cancer	0.000522	0.0109	CcSEcCtD
Argatroban—Vasodilation procedure—Epirubicin—liver cancer	0.000522	0.0109	CcSEcCtD
Argatroban—Vasodilation—Doxorubicin—liver cancer	0.000483	0.01	CcSEcCtD
Argatroban—Vasodilation procedure—Doxorubicin—liver cancer	0.000483	0.01	CcSEcCtD
Argatroban—Cough—Sorafenib—liver cancer	0.000473	0.00984	CcSEcCtD
Argatroban—Ventricular tachycardia—Epirubicin—liver cancer	0.000459	0.00953	CcSEcCtD
Argatroban—Pulmonary embolism—Epirubicin—liver cancer	0.000459	0.00953	CcSEcCtD
Argatroban—CYP3A4—liver—liver cancer	0.000451	0.00412	CbGeAlD
Argatroban—Infection—Sorafenib—liver cancer	0.00044	0.00914	CcSEcCtD
Argatroban—Pulmonary embolism—Doxorubicin—liver cancer	0.000424	0.00882	CcSEcCtD
Argatroban—Ventricular tachycardia—Doxorubicin—liver cancer	0.000424	0.00882	CcSEcCtD
Argatroban—Pulmonary oedema—Epirubicin—liver cancer	0.000408	0.00849	CcSEcCtD
Argatroban—Sepsis—Epirubicin—liver cancer	0.000398	0.00827	CcSEcCtD
Argatroban—Dyspnoea—Sorafenib—liver cancer	0.000395	0.00821	CcSEcCtD
Argatroban—Dyspepsia—Sorafenib—liver cancer	0.00039	0.0081	CcSEcCtD
Argatroban—Thrombophlebitis—Epirubicin—liver cancer	0.000384	0.00799	CcSEcCtD
Argatroban—Gastrointestinal disorder—Sorafenib—liver cancer	0.000382	0.00795	CcSEcCtD
Argatroban—Pain—Sorafenib—liver cancer	0.000379	0.00787	CcSEcCtD
Argatroban—Constipation—Sorafenib—liver cancer	0.000379	0.00787	CcSEcCtD
Argatroban—Pulmonary oedema—Doxorubicin—liver cancer	0.000378	0.00785	CcSEcCtD
Argatroban—Sepsis—Doxorubicin—liver cancer	0.000368	0.00765	CcSEcCtD
Argatroban—Gastrointestinal pain—Sorafenib—liver cancer	0.000362	0.00753	CcSEcCtD
Argatroban—Renal failure acute—Epirubicin—liver cancer	0.000361	0.0075	CcSEcCtD
Argatroban—Thrombophlebitis—Doxorubicin—liver cancer	0.000356	0.0074	CcSEcCtD
Argatroban—Abdominal pain—Sorafenib—liver cancer	0.00035	0.00728	CcSEcCtD
Argatroban—Body temperature increased—Sorafenib—liver cancer	0.00035	0.00728	CcSEcCtD
Argatroban—Renal impairment—Epirubicin—liver cancer	0.00035	0.00727	CcSEcCtD
Argatroban—Dermatitis bullous—Epirubicin—liver cancer	0.000348	0.00724	CcSEcCtD
Argatroban—Cardiac failure—Epirubicin—liver cancer	0.000341	0.00709	CcSEcCtD
Argatroban—Cerebrovascular accident—Epirubicin—liver cancer	0.00034	0.00706	CcSEcCtD
Argatroban—Renal failure acute—Doxorubicin—liver cancer	0.000334	0.00694	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000333	0.00692	CcSEcCtD
Argatroban—Hypersensitivity—Sorafenib—liver cancer	0.000326	0.00678	CcSEcCtD
Argatroban—Renal impairment—Doxorubicin—liver cancer	0.000324	0.00673	CcSEcCtD
Argatroban—Dermatitis bullous—Doxorubicin—liver cancer	0.000322	0.0067	CcSEcCtD
Argatroban—Cardiac arrest—Epirubicin—liver cancer	0.000316	0.00658	CcSEcCtD
Argatroban—Cardiac failure—Doxorubicin—liver cancer	0.000316	0.00656	CcSEcCtD
Argatroban—Cerebrovascular accident—Doxorubicin—liver cancer	0.000314	0.00653	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000308	0.0064	CcSEcCtD
Argatroban—Diarrhoea—Sorafenib—liver cancer	0.000303	0.0063	CcSEcCtD
Argatroban—Cardiac arrest—Doxorubicin—liver cancer	0.000293	0.00609	CcSEcCtD
Argatroban—Dizziness—Sorafenib—liver cancer	0.000293	0.00609	CcSEcCtD
Argatroban—Vomiting—Sorafenib—liver cancer	0.000281	0.00585	CcSEcCtD
Argatroban—Angina pectoris—Epirubicin—liver cancer	0.00028	0.00583	CcSEcCtD
Argatroban—Rash—Sorafenib—liver cancer	0.000279	0.0058	CcSEcCtD
Argatroban—Dermatitis—Sorafenib—liver cancer	0.000279	0.0058	CcSEcCtD
Argatroban—Headache—Sorafenib—liver cancer	0.000277	0.00577	CcSEcCtD
Argatroban—Nausea—Sorafenib—liver cancer	0.000263	0.00547	CcSEcCtD
Argatroban—Angina pectoris—Doxorubicin—liver cancer	0.000259	0.00539	CcSEcCtD
Argatroban—Pneumonia—Epirubicin—liver cancer	0.000258	0.00536	CcSEcCtD
Argatroban—Urinary tract infection—Epirubicin—liver cancer	0.000249	0.00518	CcSEcCtD
Argatroban—Haematuria—Epirubicin—liver cancer	0.000245	0.00508	CcSEcCtD
Argatroban—Pneumonia—Doxorubicin—liver cancer	0.000239	0.00496	CcSEcCtD
Argatroban—Bradycardia—Epirubicin—liver cancer	0.000234	0.00487	CcSEcCtD
Argatroban—Haemoglobin—Epirubicin—liver cancer	0.000231	0.00481	CcSEcCtD
Argatroban—Urinary tract infection—Doxorubicin—liver cancer	0.000231	0.0048	CcSEcCtD
Argatroban—Haemorrhage—Epirubicin—liver cancer	0.00023	0.00479	CcSEcCtD
Argatroban—Haematuria—Doxorubicin—liver cancer	0.000226	0.00471	CcSEcCtD
Argatroban—Bradycardia—Doxorubicin—liver cancer	0.000217	0.00451	CcSEcCtD
Argatroban—Haemoglobin—Doxorubicin—liver cancer	0.000214	0.00445	CcSEcCtD
Argatroban—Haemorrhage—Doxorubicin—liver cancer	0.000213	0.00443	CcSEcCtD
Argatroban—Angiopathy—Epirubicin—liver cancer	0.000209	0.00434	CcSEcCtD
Argatroban—Back pain—Epirubicin—liver cancer	0.000194	0.00403	CcSEcCtD
Argatroban—Angiopathy—Doxorubicin—liver cancer	0.000193	0.00402	CcSEcCtD
Argatroban—Back pain—Doxorubicin—liver cancer	0.000179	0.00373	CcSEcCtD
Argatroban—Cough—Epirubicin—liver cancer	0.000175	0.00364	CcSEcCtD
Argatroban—Chest pain—Epirubicin—liver cancer	0.000171	0.00355	CcSEcCtD
Argatroban—Confusional state—Epirubicin—liver cancer	0.000165	0.00343	CcSEcCtD
Argatroban—Infection—Epirubicin—liver cancer	0.000163	0.00338	CcSEcCtD
Argatroban—Cough—Doxorubicin—liver cancer	0.000162	0.00337	CcSEcCtD
Argatroban—Tachycardia—Epirubicin—liver cancer	0.00016	0.00332	CcSEcCtD
Argatroban—Chest pain—Doxorubicin—liver cancer	0.000158	0.00328	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—liver cancer	0.000154	0.00318	CbGpPWpGaD
Argatroban—Hypotension—Epirubicin—liver cancer	0.000153	0.00318	CcSEcCtD
Argatroban—Confusional state—Doxorubicin—liver cancer	0.000153	0.00317	CcSEcCtD
Argatroban—CYP3A5—Metapathway biotransformation—NAT2—liver cancer	0.000152	0.00314	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR4—liver cancer	0.000152	0.00312	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000151	0.00312	CbGpPWpGaD
Argatroban—Infection—Doxorubicin—liver cancer	0.00015	0.00313	CcSEcCtD
Argatroban—Tachycardia—Doxorubicin—liver cancer	0.000148	0.00307	CcSEcCtD
Argatroban—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000147	0.00303	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CB—liver cancer	0.000146	0.00302	CbGpPWpGaD
Argatroban—Dyspnoea—Epirubicin—liver cancer	0.000146	0.00303	CcSEcCtD
Argatroban—Dyspepsia—Epirubicin—liver cancer	0.000144	0.00299	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000143	0.00295	CbGpPWpGaD
Argatroban—Hypotension—Doxorubicin—liver cancer	0.000141	0.00294	CcSEcCtD
Argatroban—Gastrointestinal disorder—Epirubicin—liver cancer	0.000141	0.00294	CcSEcCtD
Argatroban—Pain—Epirubicin—liver cancer	0.00014	0.00291	CcSEcCtD
Argatroban—Constipation—Epirubicin—liver cancer	0.00014	0.00291	CcSEcCtD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.00014	0.00288	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CG—liver cancer	0.000138	0.00284	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—APC—liver cancer	0.000138	0.00284	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000136	0.0028	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—liver cancer	0.000136	0.00279	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000135	0.00279	CbGpPWpGaD
Argatroban—Dyspnoea—Doxorubicin—liver cancer	0.000135	0.00281	CcSEcCtD
Argatroban—Feeling abnormal—Epirubicin—liver cancer	0.000135	0.0028	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—IL6—liver cancer	0.000134	0.00277	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000134	0.00277	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000134	0.00276	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Epirubicin—liver cancer	0.000134	0.00278	CcSEcCtD
Argatroban—Dyspepsia—Doxorubicin—liver cancer	0.000133	0.00277	CcSEcCtD
Argatroban—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000131	0.00272	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—BRAF—liver cancer	0.00013	0.00267	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GPX3—liver cancer	0.000129	0.00267	CbGpPWpGaD
Argatroban—Constipation—Doxorubicin—liver cancer	0.000129	0.00269	CcSEcCtD
Argatroban—Pain—Doxorubicin—liver cancer	0.000129	0.00269	CcSEcCtD
Argatroban—Abdominal pain—Epirubicin—liver cancer	0.000129	0.00269	CcSEcCtD
Argatroban—Body temperature increased—Epirubicin—liver cancer	0.000129	0.00269	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—liver cancer	0.000126	0.0026	CbGpPWpGaD
Argatroban—Feeling abnormal—Doxorubicin—liver cancer	0.000125	0.00259	CcSEcCtD
Argatroban—Gastrointestinal pain—Doxorubicin—liver cancer	0.000124	0.00257	CcSEcCtD
Argatroban—CYP3A5—Biological oxidations—HPGDS—liver cancer	0.000123	0.00254	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CD—liver cancer	0.000121	0.0025	CbGpPWpGaD
Argatroban—Hypersensitivity—Epirubicin—liver cancer	0.000121	0.00251	CcSEcCtD
Argatroban—Body temperature increased—Doxorubicin—liver cancer	0.00012	0.00249	CcSEcCtD
Argatroban—Abdominal pain—Doxorubicin—liver cancer	0.00012	0.00249	CcSEcCtD
Argatroban—F2—Folate Metabolism—TP53—liver cancer	0.000119	0.00246	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINA1—liver cancer	0.000118	0.00244	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CHN2—liver cancer	0.000115	0.00238	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000112	0.00232	CbGpPWpGaD
Argatroban—Diarrhoea—Epirubicin—liver cancer	0.000112	0.00233	CcSEcCtD
Argatroban—Hypersensitivity—Doxorubicin—liver cancer	0.000112	0.00232	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL6—liver cancer	0.000109	0.00225	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000109	0.00224	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.000108	0.00223	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—RAF1—liver cancer	0.000108	0.00223	CbGpPWpGaD
Argatroban—Dizziness—Epirubicin—liver cancer	0.000108	0.00225	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—TNF—liver cancer	0.000108	0.00222	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000107	0.00221	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CB—liver cancer	0.000106	0.00218	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IFT88—liver cancer	0.000106	0.00217	CbGpPWpGaD
Argatroban—Vomiting—Epirubicin—liver cancer	0.000104	0.00216	CcSEcCtD
Argatroban—Diarrhoea—Doxorubicin—liver cancer	0.000104	0.00215	CcSEcCtD
Argatroban—Rash—Epirubicin—liver cancer	0.000103	0.00214	CcSEcCtD
Argatroban—Dermatitis—Epirubicin—liver cancer	0.000103	0.00214	CcSEcCtD
Argatroban—Headache—Epirubicin—liver cancer	0.000102	0.00213	CcSEcCtD
Argatroban—CYP3A5—Biological oxidations—CYP2E1—liver cancer	0.000101	0.00207	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	0.000101	0.00207	CbGpPWpGaD
Argatroban—Dizziness—Doxorubicin—liver cancer	0.0001	0.00208	CcSEcCtD
Argatroban—CYP3A5—Metapathway biotransformation—CYP2E1—liver cancer	9.92e-05	0.00204	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—KRAS—liver cancer	9.72e-05	0.002	CbGpPWpGaD
Argatroban—Nausea—Epirubicin—liver cancer	9.72e-05	0.00202	CcSEcCtD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	9.65e-05	0.00199	CbGpPWpGaD
Argatroban—Vomiting—Doxorubicin—liver cancer	9.62e-05	0.002	CcSEcCtD
Argatroban—Rash—Doxorubicin—liver cancer	9.54e-05	0.00198	CcSEcCtD
Argatroban—Dermatitis—Doxorubicin—liver cancer	9.53e-05	0.00198	CcSEcCtD
Argatroban—Headache—Doxorubicin—liver cancer	9.48e-05	0.00197	CcSEcCtD
Argatroban—F2—Metabolism of proteins—ATF3—liver cancer	9.38e-05	0.00193	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	9.29e-05	0.00191	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GGT1—liver cancer	9.24e-05	0.0019	CbGpPWpGaD
Argatroban—Nausea—Doxorubicin—liver cancer	8.99e-05	0.00187	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—TRIO—liver cancer	8.93e-05	0.00184	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CA—liver cancer	8.93e-05	0.00184	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	8.84e-05	0.00182	CbGpPWpGaD
Argatroban—F2—Hemostasis—IFNA1—liver cancer	8.82e-05	0.00182	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	8.81e-05	0.00181	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	8.74e-05	0.0018	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—ALB—liver cancer	8.73e-05	0.0018	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—liver cancer	8.69e-05	0.00179	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—NR1H4—liver cancer	8.59e-05	0.00177	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR4—liver cancer	8.56e-05	0.00176	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTA3—liver cancer	8.44e-05	0.00174	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	8.33e-05	0.00172	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTP1—liver cancer	8.3e-05	0.00171	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—HRAS—liver cancer	8.26e-05	0.0017	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTP1—liver cancer	8.18e-05	0.00169	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TRIO—liver cancer	8.11e-05	0.00167	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	8.07e-05	0.00166	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—RAF1—liver cancer	7.89e-05	0.00163	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	7.8e-05	0.00161	CbGpPWpGaD
Argatroban—F2—Hemostasis—PRKCE—liver cancer	7.8e-05	0.00161	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR4—liver cancer	7.78e-05	0.0016	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTA4—liver cancer	7.72e-05	0.00159	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	7.71e-05	0.00159	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	7.7e-05	0.00159	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—liver cancer	7.62e-05	0.00157	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	7.61e-05	0.00157	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTA2—liver cancer	7.52e-05	0.00155	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	7.52e-05	0.00155	CbGpPWpGaD
Argatroban—F2—Hemostasis—ABL1—liver cancer	7.42e-05	0.00153	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF2—liver cancer	7.39e-05	0.00152	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTA1—liver cancer	7.26e-05	0.0015	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1A1—liver cancer	7.23e-05	0.00149	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—NAT2—liver cancer	7.18e-05	0.00148	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	7.13e-05	0.00147	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	7.08e-05	0.00146	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—liver cancer	7.08e-05	0.00146	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—KRAS—liver cancer	7.01e-05	0.00144	CbGpPWpGaD
Argatroban—F2—Hemostasis—HGF—liver cancer	6.98e-05	0.00144	CbGpPWpGaD
Argatroban—F2—Hemostasis—CSF2—liver cancer	6.9e-05	0.00142	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SHC3—liver cancer	6.47e-05	0.00133	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—liver cancer	6.44e-05	0.00133	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	6.33e-05	0.0013	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	6.02e-05	0.00124	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—liver cancer	6.01e-05	0.00124	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF2—liver cancer	5.81e-05	0.0012	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—HPGDS—liver cancer	5.74e-05	0.00118	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK14—liver cancer	5.59e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB1—liver cancer	5.52e-05	0.00114	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—UGDH—liver cancer	5.41e-05	0.00111	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—liver cancer	5.37e-05	0.00111	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	5.23e-05	0.00108	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—liver cancer	5.18e-05	0.00107	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—EPT1—liver cancer	5.08e-05	0.00105	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FST—liver cancer	5.02e-05	0.00103	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PRKCE—liver cancer	4.93e-05	0.00102	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TAT—liver cancer	4.82e-05	0.000993	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	4.8e-05	0.000989	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TRIO—liver cancer	4.79e-05	0.000987	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	4.7e-05	0.000968	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2E1—liver cancer	4.68e-05	0.000964	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	4.61e-05	0.00095	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR4—liver cancer	4.59e-05	0.000947	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CD—liver cancer	4.56e-05	0.000939	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINE1—liver cancer	4.51e-05	0.000929	CbGpPWpGaD
Argatroban—F2—Hemostasis—ALB—liver cancer	4.5e-05	0.000927	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PRKCE—liver cancer	4.48e-05	0.000923	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	4.44e-05	0.000915	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CSF2—liver cancer	4.36e-05	0.000899	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GGT1—liver cancer	4.29e-05	0.000885	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	4.25e-05	0.000876	CbGpPWpGaD
Argatroban—F2—Hemostasis—RAF1—liver cancer	4.07e-05	0.000838	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CB—liver cancer	3.97e-05	0.000818	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CSF2—liver cancer	3.96e-05	0.000816	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTP1—liver cancer	3.86e-05	0.000795	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.84e-05	0.000791	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	3.8e-05	0.000784	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—liver cancer	3.65e-05	0.000752	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADAM17—liver cancer	3.63e-05	0.000748	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—liver cancer	3.61e-05	0.000744	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—liver cancer	3.54e-05	0.00073	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	3.5e-05	0.00072	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PSMA4—liver cancer	3.41e-05	0.000703	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PSMD10—liver cancer	3.41e-05	0.000703	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.36e-05	0.000692	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.31e-05	0.000683	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—liver cancer	3.28e-05	0.000675	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CPT1B—liver cancer	3.28e-05	0.000675	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GLUL—liver cancer	3.28e-05	0.000675	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NR1H4—liver cancer	3.16e-05	0.000651	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA3—liver cancer	3.11e-05	0.00064	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—liver cancer	3.1e-05	0.000639	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—liver cancer	2.97e-05	0.000613	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—liver cancer	2.88e-05	0.000593	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—liver cancer	2.85e-05	0.000586	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA4—liver cancer	2.84e-05	0.000585	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—liver cancer	2.77e-05	0.000571	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA2—liver cancer	2.77e-05	0.00057	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA1—liver cancer	2.67e-05	0.00055	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCE—liver cancer	2.65e-05	0.000545	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NAT2—liver cancer	2.64e-05	0.000544	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—liver cancer	2.64e-05	0.000543	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—liver cancer	2.62e-05	0.000539	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALDOB—liver cancer	2.53e-05	0.000522	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UGDH—liver cancer	2.51e-05	0.000518	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—liver cancer	2.51e-05	0.000517	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF2—liver cancer	2.51e-05	0.000516	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—liver cancer	2.42e-05	0.000499	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CRABP1—liver cancer	2.41e-05	0.000498	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—EPT1—liver cancer	2.36e-05	0.000487	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—liver cancer	2.34e-05	0.000483	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CSF2—liver cancer	2.34e-05	0.000482	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—RAF1—liver cancer	2.33e-05	0.000481	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—H2AFX—liver cancer	2.31e-05	0.000475	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—liver cancer	2.31e-05	0.000475	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—liver cancer	2.28e-05	0.00047	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TAT—liver cancer	2.24e-05	0.000462	CbGpPWpGaD
Argatroban—F2—Hemostasis—HRAS—liver cancer	2.24e-05	0.000462	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HPGDS—liver cancer	2.11e-05	0.000435	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—liver cancer	2.09e-05	0.000431	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—liver cancer	2.09e-05	0.00043	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—liver cancer	1.98e-05	0.000408	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—liver cancer	1.91e-05	0.000393	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK14—liver cancer	1.9e-05	0.00039	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMA4—liver cancer	1.88e-05	0.000388	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMD10—liver cancer	1.88e-05	0.000388	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—liver cancer	1.86e-05	0.000383	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GOT2—liver cancer	1.83e-05	0.000377	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—liver cancer	1.76e-05	0.000362	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—liver cancer	1.76e-05	0.000362	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2E1—liver cancer	1.72e-05	0.000355	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BRAF—liver cancer	1.65e-05	0.00034	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYCS—liver cancer	1.61e-05	0.000332	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GGT1—liver cancer	1.58e-05	0.000325	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GOT1—liver cancer	1.58e-05	0.000325	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—liver cancer	1.54e-05	0.000318	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—liver cancer	1.53e-05	0.000315	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SERPINE1—liver cancer	1.53e-05	0.000315	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GLUL—liver cancer	1.52e-05	0.000314	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CPT1B—liver cancer	1.52e-05	0.000314	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—liver cancer	1.51e-05	0.000312	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NR1H4—liver cancer	1.47e-05	0.000303	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA3—liver cancer	1.44e-05	0.000297	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—liver cancer	1.42e-05	0.000292	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMOX1—liver cancer	1.4e-05	0.000288	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—liver cancer	1.39e-05	0.000286	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RAF1—liver cancer	1.38e-05	0.000284	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MTOR—liver cancer	1.35e-05	0.000277	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—liver cancer	1.35e-05	0.000277	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA4—liver cancer	1.32e-05	0.000272	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—liver cancer	1.3e-05	0.000269	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA2—liver cancer	1.29e-05	0.000265	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRAS—liver cancer	1.29e-05	0.000265	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—liver cancer	1.26e-05	0.00026	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—liver cancer	1.25e-05	0.000258	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA1—liver cancer	1.24e-05	0.000256	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—liver cancer	1.24e-05	0.000255	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—liver cancer	1.24e-05	0.000255	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A1—liver cancer	1.24e-05	0.000255	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—liver cancer	1.23e-05	0.000254	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAT2—liver cancer	1.23e-05	0.000253	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—liver cancer	1.21e-05	0.000248	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JUN—liver cancer	1.2e-05	0.000248	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—liver cancer	1.19e-05	0.000246	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDOB—liver cancer	1.18e-05	0.000242	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—liver cancer	1.17e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1A—liver cancer	1.17e-05	0.00024	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—liver cancer	1.15e-05	0.000237	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK8—liver cancer	1.14e-05	0.000235	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—liver cancer	1.14e-05	0.000234	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARA—liver cancer	1.13e-05	0.000233	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CRABP1—liver cancer	1.12e-05	0.000231	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—liver cancer	1.05e-05	0.000217	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—liver cancer	1.04e-05	0.000214	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HPGDS—liver cancer	9.81e-06	0.000202	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—liver cancer	9.68e-06	0.000199	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—liver cancer	9.67e-06	0.000199	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—liver cancer	9.65e-06	0.000199	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—liver cancer	9.35e-06	0.000193	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—liver cancer	8.93e-06	0.000184	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMD10—liver cancer	8.75e-06	0.00018	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMA4—liver cancer	8.75e-06	0.00018	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—liver cancer	8.51e-06	0.000175	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GOT2—liver cancer	8.51e-06	0.000175	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—liver cancer	8.4e-06	0.000173	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—liver cancer	8.21e-06	0.000169	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2E1—liver cancer	8e-06	0.000165	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—liver cancer	7.94e-06	0.000164	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRAS—liver cancer	7.59e-06	0.000156	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYCS—liver cancer	7.48e-06	0.000154	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—liver cancer	7.42e-06	0.000153	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GGT1—liver cancer	7.34e-06	0.000151	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GOT1—liver cancer	7.34e-06	0.000151	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—liver cancer	7.27e-06	0.00015	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—liver cancer	6.71e-06	0.000138	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—liver cancer	6.6e-06	0.000136	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMOX1—liver cancer	6.51e-06	0.000134	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—liver cancer	6.06e-06	0.000125	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A1—liver cancer	5.75e-06	0.000118	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—liver cancer	5.36e-06	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARA—liver cancer	5.26e-06	0.000108	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—liver cancer	4.52e-06	9.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—liver cancer	4.5e-06	9.27e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—liver cancer	4.34e-06	8.95e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—liver cancer	3.96e-06	8.15e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—liver cancer	3.91e-06	8.05e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—liver cancer	3.69e-06	7.61e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—liver cancer	3.45e-06	7.11e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—liver cancer	2.1e-06	4.33e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—liver cancer	1.72e-06	3.54e-05	CbGpPWpGaD
